These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35767209)

  • 1. Renoprotective effects of empagliflozin in type 1 and type 2 models of diabetic nephropathy superimposed with hypertension.
    Williams JM; Murphy SR; Wu W; Border JJ; Fan F; Roman RJ
    Geroscience; 2022 Dec; 44(6):2845-2861. PubMed ID: 35767209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a new SGLT2 inhibitor, luseogliflozin, on diabetic nephropathy in T2DN rats.
    Kojima N; Williams JM; Takahashi T; Miyata N; Roman RJ
    J Pharmacol Exp Ther; 2013 Jun; 345(3):464-72. PubMed ID: 23492941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the development of renal injury in Type-1 diabetic Dahl salt-sensitive rats.
    Slaughter TN; Paige A; Spires D; Kojima N; Kyle PB; Garrett MR; Roman RJ; Williams JM
    Am J Physiol Regul Integr Comp Physiol; 2013 Oct; 305(7):R727-34. PubMed ID: 23926133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of metalloprotease inhibitors on hypertension and diabetic nephropathy.
    Williams JM; Zhang J; North P; Lacy S; Yakes M; Dahly-Vernon A; Roman RJ
    Am J Physiol Renal Physiol; 2011 Apr; 300(4):F983-98. PubMed ID: 21228113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effects of lisinopril and empagliflozin in a mouse model of hypertension-accelerated diabetic kidney disease.
    Østergaard MV; Secher T; Christensen M; Salinas CG; Roostalu U; Skytte JL; Rune I; Hansen HH; Jelsing J; Vrang N; Fink LN
    Am J Physiol Renal Physiol; 2021 Aug; 321(2):F149-F161. PubMed ID: 34180715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of the progression of renal injury in diabetic rodent models with preexisting renal disease with chronic endothelin A receptor blockade.
    Spires D; Poudel B; Shields CA; Pennington A; Fizer B; Taylor L; McPherson KC; Cornelius DC; Williams JM
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F977-F985. PubMed ID: 29846112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renoprotective effects of combined SGLT2 and ACE inhibitor therapy in diabetic Dahl S rats.
    Kojima N; Williams JM; Slaughter TN; Kato S; Takahashi T; Miyata N; Roman RJ
    Physiol Rep; 2015 Jul; 3(7):. PubMed ID: 26169541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice.
    Vallon V; Gerasimova M; Rose MA; Masuda T; Satriano J; Mayoux E; Koepsell H; Thomson SC; Rieg T
    Am J Physiol Renal Physiol; 2014 Jan; 306(2):F194-204. PubMed ID: 24226524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic treatment with lisinopril on cardiovascular complications in streptozotocin diabetic and DOCA hypertensive rats.
    Sevak AR; Goyal RK
    Pharmacol Res; 1996; 34(5-6):201-9. PubMed ID: 9076844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockout of Matrix Metalloproteinase 2 Opposes Hypertension- and Diabetes-induced Nephropathy.
    Hirata T; Fan F; Fan L; Amin G; White T; Geurts AM; Kojima N; Takahashi T; Miyata N; Williams J; Roman RJ
    J Cardiovasc Pharmacol; 2023 Dec; 82(6):445-457. PubMed ID: 37643020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive effects of cilnidipine and angiotensin II receptor blocker in preventing the progression of diabetic nephropathy in diabetic spontaneously hypertensive rats.
    Aritomi S; Niinuma K; Ogawa T; Konda T; Nitta K
    Clin Exp Nephrol; 2013 Feb; 17(1):41-50. PubMed ID: 23011292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SGLT2 inhibitor empagliflozin ameliorates early features of diabetic nephropathy in BTBR ob/ob type 2 diabetic mice with and without hypertension.
    Gembardt F; Bartaun C; Jarzebska N; Mayoux E; Todorov VT; Hohenstein B; Hugo C
    Am J Physiol Renal Physiol; 2014 Aug; 307(3):F317-25. PubMed ID: 24944269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative antihypertensive and renoprotective effects of telmisartan and lisinopril after long-term treatment in hypertensive diabetic rats.
    Wienen W; Richard S; Champeroux P; Audeval-Gerard C
    J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1):31-6. PubMed ID: 11881063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Betanin, isolated from fruits of Opuntia elatior Mill attenuates renal fibrosis in diabetic rats through regulating oxidative stress and TGF-β pathway.
    Sutariya B; Saraf M
    J Ethnopharmacol; 2017 Feb; 198():432-443. PubMed ID: 28111218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of Naringenin and Lisinopril Ameliorates Nephropathy in Type-1 Diabetic Rats.
    Kulkarni YA; Suryavanshi SV
    Endocr Metab Immune Disord Drug Targets; 2021; 21(1):173-182. PubMed ID: 32416710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empagliflozin alone and in combination with metformin mitigates diabetes-associated renal complications.
    Madhag Z; Al-Isawi Z
    J Med Life; 2024 May; 17(5):530-535. PubMed ID: 39144694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antihypertensive therapy on renal injury in type 2 diabetic rats with hypertension.
    Reddi AS; Nimmagadda VR; Lefkowitz A; Kuo HR; Bollineni JS
    Hypertension; 2000 Aug; 36(2):233-8. PubMed ID: 10948083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in the rat.
    Balakumar P; Chakkarwar VA; Singh M
    Mol Cell Biochem; 2009 Jan; 320(1-2):149-62. PubMed ID: 18830571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced renal ischemia-reperfusion injury in aging and diabetes.
    Muroya Y; He X; Fan L; Wang S; Xu R; Fan F; Roman RJ
    Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1843-F1854. PubMed ID: 30207168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.